Industrial Biomanufacturing 2027-2037: Technologies, Markets, Players, Forecasts

Industrial biomanufacturing for chemicals and materials applications. Industrial fermentation processes. Technology analysis and outlook for 35+ biomanufactured molecules. Biomanufacturing market appraisal and 10-year market forecast.

Show All Description Contents, Table & Figures List FAQs Pricing Related Content
Key aspects of this report
  • Discussion of industrial biomanufacturing within the bioeconomy.
  • Overview of biomanufacturing's application in fuels, plastics, textiles, additives, precursors, and other chemicals.
  • Identification of 35+ biobased molecules produced through biomanufacturing.
  • 30+ granular technology analyses for major biomanufactured molecules, including biomanufacturing process, technology readiness level, challenges, comparison against petroleum incumbent, and downstream applications.
  • Benchmarking of current production capacity and outlook for major biobased molecules, including lactic acid, butanediol, propanediol, PHAs, long chain dicarboxylic acids, etc.
  • Analysis of synthetic biology and its impact on industrial biomanufacturing.
  • Technology developments influencing industrial biomanufacturing, including cell-free systems, gaseous and lignocellulosic feedstock, and novel biocatalysts.
  • The impact of technology developments with AI and machine learning on biomanufacturing.
  • Assessment of market drivers (governments, companies, and the public) and key technical challenges for biomanufacturing.
  • Pain points affecting economic viability for industrial biomanufacturing.
  • Discussion of current projects and previous efforts in industrial biomanufacturing, including analysis of factors for success and failure.
  • Detailed 10-year market forecasts segmented by major biomanufactured molecules, including lactic acid, butanediol, PHAs, succinic acid, and other organic acids.
  • Identification of 100+ emerging and established players operating in industrial biomanufacturing, segmented by molecule.
Report description
Industrial biomanufacturing for a resilient bioeconomy
Bioeconomy is an economic system in which society uses renewable biological resources derived from land, fisheries, and aquaculture to create biobased products such as food, nutrients, chemicals, materials, and fuels. Because these resources can often be sourced close to where they are grown or processed, the bioeconomy offers a path to a more resilient, sustainable economic model, one less exposed to the long, fragile supply chains that have repeatedly disrupted the materials and chemicals industry. That vulnerability is sharpened by the sector's continued dependence on globally traded fossil fuels, making the case for biobased alternatives more urgent than ever.
 
Industrial biomanufacturing is vital to building this resilient bioeconomy. As a key technology enabler, it allows commodity chemicals to be produced through biological systems running on renewable, locally sourced feedstocks, which shorten supply chains, reduce exposure to volatile international markets, and keep more economic value within local and regional economies.
 
In Industrial Biomanufacturing 2027-2037, IDTechEx provides independent analysis of the sector's status, critically examining technology innovations and past, current, and future projects to deliver an objective assessment of industrial biomanufacturing's future.
 
 
What is industrial biomanufacturing, and why does it matter?
Industrial biomanufacturing (as known as white biotechnology, industrial biotechnology, and bioindustrial manufacturing) uses microorganisms (bacteria, fungi, yeast, and others) and enzymes to produce commercial materials and chemicals from renewable feedstocks. It offers a more sustainable alternative to petroleum-based chemical production, one that reduces reliance on fossil fuels, uses less energy, generates less waste, and can yield biodegradable products that are better for the environment.
 
Industrial biomanufacturing - installed production capacity by region 2027
Distribution of industrial biomanufacturing installed production capacity by region in 2027. Source: IDTechEx.
 
This IDTechEx report examines the technology innovations fueling the growth and rising relevance of industrial biomanufacturing. Advances in biotechnology tools, techniques, and processes now enable the production of a wide range of products. The report provides detailed analyses of the status, technical benefits and challenges, and commercial activity of:
  • Novel biocatalysts for industrial fermentation
  • Improvements to bioprocesses
  • Cell-free systems
  • Alternative feedstocks, including gases and cellulosic materials
  • AI and automation for biomanufacturing
 
A diverse spectrum of biobased products
Biomanufacturing yields a remarkably diverse range of chemicals and materials including alcohols, diols, diamines, organic acids, polymers, etc, used across textiles, packaging, lubricants, adhesives, and additives. The report provides technical and market analysis of 35+ biomanufactured molecules, covering:
  • The biomanufacturing process
  • Comparison with petrochemical equivalents
  • Technical advantages and current challenges
  • Downstream products and end-applications
  • Technology readiness level
  • Key players in development and production
  • Market outlook
 
Together, these insights offer a clear picture of the industry's status and growing versatility.
Products of industrial biomanufacturing. Source: IDTechEx.
 
Lactic acid: Accelerating growth through regulation-driven PLA demand
Among the molecules covered, lactic acid stands out for its rapid growth, driven by rising demand for polylactic acid (PLA). This biodegradable polymer is increasingly replacing fossil-based plastics in packaging and consumer goods. The shift is accelerated by tightening environmental regulations, especially in China, where restrictions on non-biodegradable plastics are pushing the market toward compostable alternatives. As producers worldwide scale up PLA capacity, demand is rippling through the entire lactic acid supply chain.
 
The Impact of AI on industrial biomanufacturing
AI is becoming a pivotal enabler of industrial biomanufacturing. It speeds enzyme discovery and protein engineering by rapidly screening candidate molecules. AI also accelerates strain engineering by analyzing genomic and metabolic data to identify modifications that improve yield, tolerance, and productivity in microbial cell factories. In bioprocess development, machine learning optimizes fermentation conditions in silico, reducing the need for costly lab trials. As industrial biomanufacturing's applications expand, AI integration promises major gains in efficiency, scalability, and cost effectiveness, strengthening the field's value proposition as a sustainable alternative to petrochemical production.
 
An active market of established and emerging players
IDTechEx has considered more than 100 companies, from multinational conglomerates to early-stage startups, that are pursuing industrial biomanufacturing. This report maps their activity: partnerships, funding, past and ongoing projects, target molecules, and production capacity. Interview-based company profiles of key players add further depth to the analysis.
 
Player landscape is just one piece of the puzzle. Economic viability of industrial manufacturing also depends on internal factors like process yield, scalability, and biocatalyst performance, and external factors such as regulation, crude oil prices, and the green premium. This report weighs all of these to explain the industry's trajectory to date and what will shape its future.
 
A 10-year market forecast by major molecules
The market forecast for industrial biomanufacturing is segmented by 10 major biomanufactured molecules, ranked by global production capacity. For each, it examines current capacity, drivers, and constraints, then projects a 10-year forecast, highlighting mature and emerging products, technology readiness, disruption potential, and the future shape of the industry.
Report MetricsDetails
CAGRBiomanufactured chemicals (excluding fuels) to grow at 13% CAGR from 2027-2037.
Forecast Period2027 - 2037
Forecast Unitskilotonnes per annum (ktpa)
Regions CoveredWorldwide
Segments CoveredLactic Acid, polyhydroxyalkanoate (PHA), Long chain dicarboxylic acids (LCDAs), 1,3-propanediol, 1,4-butanediol, succinic Acid, 1,5-pentanediamine, short and medium chain fatty acids (SCFAs and MCFAs), other organic acids, and all others.
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan and Korea): +81 3 3216 7209
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.Glossary of terms
1.2.What is industrial biomanufacturing?
1.3.Industrial Biomanufacturing 2027-2037: Scope
1.4.Market trends and drivers in industrial biomanufacturing (1/2)
1.5.Market trends and drivers in industrial biomanufacturing (2/2)
1.6.Synthetic biology as applied to industrial biomanufacturing
1.7.Technology trends in industrial biomanufacturing
1.8.Overview of alternative feedstocks for industrial biomanufacturing
1.9.Major market challenges for industrial biomanufacturing
1.10.Technical challenges facing industrial biomanufacturing
1.11.Products derived from industrial biomanufacturing: Overview
1.12.Molecules that can be produced through industrial biomanufacturing
1.13.Molecules that can be produced through industrial biomanufacturing
1.14.Company landscape in industrial biomanufacturing (1/2)
1.15.Company landscape in industrial biomanufacturing (2/2)
1.16.Next-generation fuels through industrial biomanufacturing
1.17.Bioplastics through industrial biomanufacturing
1.18.Navigating biobased polymers from monosaccharides
1.19.Common bioplastics and polymer precursors synthesized via industrial biomanufacturing
1.20.Status of molecules produced through industrial biomanufacturing
1.21.Industrial biomanufacturing global capacity forecast 2027-2037
1.22.Industrial biomanufacturing market share by molecule 2027-2037
1.23.IDTechEx circular bioeconomy research
1.24.Company profiles
1.25.Access more with an IDTechEx subscription
2.INTRODUCTION
2.1.Glossary of terms
2.2.Biotechnology application
2.3.What is industrial biomanufacturing?
2.4.The bioeconomy and industrial biomanufacturing
2.5.Industrial Biomanufacturing 2027-2037: Scope
2.6.Molecules that can be produced through industrial biomanufacturing
2.7.Molecules that can be produced through industrial biomanufacturing
3.MARKET ANALYSIS
3.1.Market drivers for industrial biomanufacturing
3.2.Market drivers: Demand for biobased products
3.3.Overview of bioplastics regulations around the world (1/2)
3.4.Overview of bioplastics regulations around the world (2/2)
3.5.Proposed EU biobased content targets for plastic packaging
3.6.Regulations are driving strong interest in biodegradable plastics in China
3.7.US government support of biotechnology
3.8.Other policy support for biomanufacturing
3.9.Carbon taxes as a market driver
3.10.Economic viability of industrial biomanufacturing
3.11.Factors affecting the economic viability of industrial biomanufacturing projects
3.12.Effect of the price of Brent crude on biobased products
3.13.The green premium
3.14.The effect of biomass feedstock prices on the bioplastics market
3.15.Effect of cell factory on cost
3.16.Identifying the chemicals with the most potential to become biobased based on price
3.17.How scale-up affects cost
3.18.Zymergen: Case study on economics of synthetic biology
3.19.Case study: LanzaTech
3.20.Case study: Solazyme
3.21.Synthetic biology: Shift from commodity products to lower volume, high value markets
3.22.Major market challenges for industrial biomanufacturing
3.23.Players and Regional Landscape
3.24.Production capacity of chemicals from biomanufacturing by region 2027
3.25.Regional analysis: Drivers and restraints for biomanufacturing production and demand by region
3.26.Regional analysis: Location of R&D vs production
3.27.Regional analysis: Biomanufacturing
3.28.Regional analysis: Production capacity by region
3.29.Players: Synthetic biology tools and platforms
3.30.Players: Vertically integrated biomanufacturing technology provider
3.31.Emerging players segmented by molecule (1/2)
3.32.Emerging players segmented by molecule (2/2)
3.33.Overview of major chemicals and materials companies involved in industrial biomanufacturing (1/2)
3.34.Overview of major chemicals and materials companies involved in industrial biomanufacturing (2/2)
4.CELL FACTORIES FOR INDUSTRIAL BIOMANUFACTURING
4.1.Cell factories for biomanufacturing: Factors to consider
4.2.Cell factories for biomanufacturing: A range of organisms
4.3.Escherichia coli (E. coli)
4.4.Corynebacterium glutamicum (C. glutamicum)
4.5.Bacillus subtilis (B. subtilis)
4.6.Saccharomyces cerevisiae (S. cerevisiae)
4.7.Yarrowia lipolytica (Y. lipolytica)
4.8.Microorganisms used in different biomanufacturing processes
4.9.Non-model organisms for industrial biomanufacturing
5.TECHNOLOGY DEVELOPMENTS
5.1.Synthetic Biology
5.1.1.Synthetic biology: The design and engineering of biological systems
5.1.2.Synthetic biology: Manipulating the central dogma
5.1.3.The vast scope of synthetic biology
5.1.4.The process of synthetic biology: Design, build and test
5.1.5.Synthetic biology: Why now?
5.1.6.Synthetic biology: From pharmaceuticals to consumer products
5.1.7.Synthetic biology: Disrupting existing chemicals supply chains
5.1.8.Synthetic biology: Drivers and barriers for adoption
5.1.9.Synthetic biology as applied to industrial biomanufacturing
5.1.10.Tools and Techniques of Synthetic Biology
5.1.11.Tools and techniques of synthetic biology: Overview
5.1.12.DNA synthesis
5.1.13.Introduction to CRISPR-Cas9
5.1.14.CRISPR-Cas9: A bacterial immune system
5.1.15.CRISPR-Cas9's importance to synthetic biology
5.1.16.Strain construction and optimization
5.1.17.Protein/enzyme engineering
5.1.18.Computer-aided design
5.1.19.Commercial examples of engineered proteins in industrial applications
5.1.20.Synergy between synthetic biology and metabolic engineering
5.1.21.Framework for developing industrial microbial strains
5.1.22.The problem with scale
5.2.Cell-free biomanufacturing
5.2.1.Introduction to cell-free systems
5.2.2.Cell-free versus cell-based systems
5.2.3.Cell-free systems in the context of industrial biomanufacturing
5.2.4.Cell-free systems for industrial biomanufacturing
5.2.5.Commercial implementation of cell-free systems: Solugen
5.2.6.Startups pursuing cell-free systems for industrial biomanufacturing (1/2)
5.2.7.Startups pursuing cell-free systems for industrial biomanufacturing (2/2)
5.2.8.Immobilized enzymes in industrial biomanufacturing (1/2)
5.2.9.Immobilized catalysts in industrial biomanufacturing (2/2)
5.3.Improvement of Biomanufacturing Processes
5.3.1.Continuous vs batch biomanufacturing
5.3.2.Continuous perfusion bioreactors
5.3.3.Benefits and challenges of continuous biomanufacturing
5.3.4.Continuous vs. batch biomanufacturing: Key fermentation parameter comparison
5.3.5.Continuous fermentation: DAB.bio
5.3.6.Simultaneous saccharification and fermentation (SSF)
5.3.7.Sterility-free fermentation
5.3.8.Downstream processing (DSP) improvements (1/2)
5.3.9.Downstream processing (DSP) improvements (2/2)
5.3.10.Tangential flow filtration (TFF) in downstream bioprocessing
5.3.11.Hybrid biotechnological-chemical approaches
5.3.12.Process intensification and high-cell-density fermentation
5.4.Automation and AI for Biomanufacturing
5.4.1.Robotics: Enabling hands-free and high throughput science
5.4.2.Robotic cloud laboratories
5.4.3.Automating organism design and closing the loop
5.4.4.Machine learning de novo protein prediction
5.4.5.AI-driven protein/enzyme design companies
5.4.6.Machine learning to improve biomanufacturing processes
5.4.7.AI-driven fermentation platform companies
5.4.8.Overview of machine learning-based improvements for biomanufacturing
5.5.Industrial Biomanufacturing for Sustainability
5.5.1.Industrial biomanufacturing as a sustainable technology
5.5.2.Routes for carbon capture in industrial biomanufacturing
5.5.3.Autotrophic bacteria for carbon capture through biomanufacturing
5.6.Next Generation Feedstocks for Biomanufacturing
5.6.1.Why use alternative feedstocks for industrial biomanufacturing?
5.6.2.Food, land, and water competition
5.6.3.C1 feedstocks: Metabolic pathways
5.6.4.C1 feedstocks: Economic benefits
5.6.5.C1 feedstocks: Challenges
5.6.6.Non-methane C1 feedstocks
5.6.7.C1 feedstocks: Products
5.6.8.C1 feedstocks: Gas fermentation
5.6.9.C2 feedstocks
5.6.10.C2 feedstocks: Products segmented by feedstock
5.6.11.C1 and C2 feedstocks: Commercial activity (1/2)
5.6.12.C1 and C2 feedstocks: Commercial activity (2/2)
5.6.13.Lignocellulosic biomass feedstocks
5.6.14.Lignocellulosic biomass feedstocks: Challenges
5.6.15.Lignocellulosic biomass feedstocks: Challenges
5.6.16.Lignocellulosic biomass feedstocks: Products
5.6.17.Lignocellulosic feedstocks: Commercial activity
6.BLUE BIOTECHNOLOGY
6.1.What is blue biotechnology?
6.2.Main biocatalysts of blue biotechnology: Cyanobacteria and algae
6.3.Cyanobacteria
6.4.Algae
6.5.Key drivers and challenges for blue biotechnology
6.6.Selected startups in blue biotechnology
7.PRODUCTS DERIVED FROM INDUSTRIAL BIOMANUFACTURING
7.1.1.Products derived from industrial biomanufacturing: Overview
7.2.Fuels
7.2.1.Biofuel generations: Conventional & advanced biofuels
7.2.2.Biofuel generations: Feedstocks
7.2.3.Industrial biomanufacturing for biofuel production
7.2.4.Biofuel generations: Biomanufacturing process
7.2.5.Metabolic pathways to biofuels
7.2.6.Overview of 1st generation bioethanol production
7.2.7.Next-generation bioethanol
7.2.8.Next generation bioethanol: Barriers
7.2.9.Next generation bioethanol production overview
7.2.10.Diesel from biomanufacturing pathways
7.2.11.Farnesene: A case study of Amyris
7.2.12.n-Butanol
7.2.13.Isobutanol
7.2.14.Methanol
7.2.15.Blue biotechnology in biofuel production
7.2.16.Blue biotechnology in biodiesel production
7.2.17.Blue biotechnology in bioethanol production
7.2.18.Blue biotechnology for biofuel production: Key challenges for commercial viability
7.2.19.Blue biotechnology for biofuel production: Commercial activity by US oil producers
7.2.20.Blue biotechnology for biofuel production: Commercial activity by non-US oil producers
7.2.21.Blue biotechnology for biofuel production: List of current and former players
7.2.22.Blue biotechnology for biofuel production: List of current and former players
7.2.23.Blue biotechnology for biofuel production: List of current and former players
7.3.Plastics and Textiles
7.3.1.Introduction to bioplastics
7.3.2.Production of bioplastics through industrial biomanufacturing
7.3.3.Navigating biobased polymers from monosaccharides
7.3.4.Common bioplastics and polymer precursors synthesized via industrial biomanufacturing
7.3.5.Bioplastics 2026-2036
7.3.6.Lactic Acid and Polylactic Acid (PLA)
7.3.7.Lactic acid (C3H6O3)
7.3.8.Lactic acid: Microbial fermentation and chemical synthesis
7.3.9.Optimal lactic acid bacteria strains for fermentation
7.3.10.Engineering yeast strains for lactic acid fermentation
7.3.11.Fermentation, recovery and purification
7.3.12.What is polylactic acid?
7.3.13.Production of PLA
7.3.14.PLA production process
7.3.15.Polylactic acid: A SWOT analysis
7.3.16.Molecules for Other Biobased Synthetic Polyesters
7.3.17.The range of available bio-based polyesters
7.3.18.Monoethylene glycol (MEG)
7.3.19.Polyethylene terephthalate (PET)
7.3.20.Biobased MEG: Monomer production
7.3.21.Biobased MEG: Industry landscape
7.3.22.Biobased MEG: Industry landscape
7.3.23.Propylene glycol (PG) or 1,2-propanediol
7.3.24.1,3-Propanediol (1,3-PDO)
7.3.25.Biobased 1,3-PDO and PTT: Monomer production
7.3.26.Biobased 1,3-PDO and PTT: Polymer applications
7.3.27.2,3-Butanediol (2,3-BDO)
7.3.28.1,4-Butanediol (1,4-BDO)
7.3.29.Biobased 1,4-BDO: Monomer production
7.3.30.Biobased 1,4-BDO technology licensed from Geno
7.3.31.Biobased BDO and PBT: Polymer applications
7.3.32.Succinic acid
7.3.33.Biobased succinic acid: Monomer production
7.3.34.Biobased succinic acid and PBS: Polymer applications
7.3.35.Biobased succinic acid: Project status
7.3.36.2,5-furandicarboxylic acid (FDCA)
7.3.37.Biobased FDCA: Monomer production
7.3.38.Polyethylene furanoate (PEF)
7.3.39.Biobased FDCA and PEF: Polymer applications
7.3.40.Molecules for Other Biobased Synthetic Polymers
7.3.41.Biobased ethanol as a precursor to ethylene
7.3.42.Biomanufacturing of ethylene
7.3.43.Biobased polyolefins: Challenges and opportunities
7.3.44.Braskem: "I'm Green" biobased polyethylene
7.3.45.Biomanufacturing of propylene precursors
7.3.46.Biosynthetic pathways to polyamides
7.3.47.C6: Adipic acid, hexamethylenediamine, and caprolactam by Geno
7.3.48.Biosynthesis of Adipic Acid by Toray
7.3.49.C10: Sebacic acid
7.3.50.C12: Dodecanedioic acid
7.3.51.1,5-Pentanediamine (PDA)
7.3.52.Covestro: PDI and Desmodur eco aliphatic polyisocyanate
7.3.53.Cathay Industrial Biotech: TERRYL and ECOPENT biobased polyamides
7.3.54.1,3-Butadiene
7.3.55.Status of biomanufacturing-derived butadiene projects
7.3.56.Isoprene
7.3.57.Isobutene (isobutylene)
7.3.58.Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs)
7.3.59.Introduction to polyhydroxyalkanoates
7.3.60.Biosynthetic pathways to PHAs
7.3.61.Fermentation, recovery and purification of PHAs
7.3.62.Key commercial PHAs and microstructures
7.3.63.PHB, PHBV, and PHBB
7.3.64.Short and medium chain-length PHAs
7.3.65.PHA used in elastomers
7.3.66.Types of PHAs
7.3.67.Applications of PHAs
7.3.68.Opportunities in PHAs
7.3.69.Reducing the cost of PHA production
7.3.70.Risks in PHAs
7.3.71.Case Study: Danimer Scientific bankruptcy
7.3.72.PHAs: A SWOT analysis
7.3.73.PHAs are only made in small quantities
7.3.74.PHA production facilities
7.3.75.PHA: Bio-based and biodegradable certifications
7.3.76.Suppliers of PHAs
7.3.77.PHA outlook
7.3.78.Other textiles produced through industrial biomanufacturing
7.3.79.Spider silk
7.3.80.Collagen
7.3.81.Mycelium
7.4.Additives and Precursors
7.4.1.Acetone
7.4.2.Acrylic acid
7.4.3.Itaconic acid
7.4.4.Malonic acid
7.4.5.Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs)
7.4.6.Short chain fatty acids and medium chain fatty acids (SCFAs & MCFAs)
7.4.7.Short chain fatty acids: Acetic acid
7.4.8.Other organic acids and aldehydes
7.4.9.Triglycerides
7.5.Other Products Derived from Industrial Biomanufacturing
7.5.1.Bacterial cellulose
7.5.2.Overview of vitamins and amino acids produced through industrial biomanufacturing
7.5.3.Overview of industrial biomanufacturing for cosmetics
7.5.4.Enzymes for detergents
7.5.5.Enzymes for onward use: Novonesis
7.5.6.Biosurfactants
7.5.7.Cement alternatives from biomanufacturing: BioMason
7.5.8.Precision fermentation: Definition and scope
8.FORECASTS FOR INDUSTRIAL BIOMANUFACTURING
8.1.Forecast methodology
8.2.Industrial biomanufacturing global capacity forecast 2027-2037
8.3.Industrial biomanufacturing market share by molecule 2027-2037
8.4.Industrial biomanufacturing global capacity forecast 2027-2037: Discussion
8.5.Industrial biomanufacturing global capacity forecast 2027-2037: Discussion
8.6.Industrial biomanufacturing global capacity forecast 2026-2037: Discussion
8.7.Industrial biomanufacturing global capacity forecast 2027-2037: Discussion
8.8.Industrial biomanufacturing global capacity forecast 2027-2037: Discussion
9.COMPANY PROFILES
9.1.Afyren
9.2.Arzeda
9.3.Biomason
9.4.Bolt Threads
9.5.Braskem Bioplastics
9.6.CarbonBridge
9.7.Cathay Industrial Biotech
9.8.Celtic Renewables
9.9.Chaincraft
9.10.CyanoCapture
9.11.Ecovative Forager
9.12.Enginzyme
9.13.Enzymaster
9.14.Geno: 1,4-Butanediol
9.15.Geno: C6 Nylon Precursors
9.16.Industrial Microbes
9.17.Kraig Biocraft Laboratories
9.18.LanzaTech
9.19.New Energy Blue
9.20.Novozymes (now Novonesis)
9.21.Q Power
9.22.Solugen
9.23.Spiber
9.24.17Cicada
9.25.Henan Techuang Biotechnology
9.26.Huitong Biomaterials
9.27.NatureWorks
9.28.Teijin Frontier: PLA
9.29.TotalEnergies Corbion
9.30.Biotic Circular Technologies
9.31.Bluepha
9.32.CJ Biomaterials
9.33.Danimer Scientific
9.34.Fortum: INGA Plastic
9.35.Kaneka: PHAs
9.36.Mango Materials
9.37.Newlight Technologies
9.38.Ourobio
9.39.Paques Biomaterials
9.40.Shellworks
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 

Ordering Information

Industrial Biomanufacturing 2027-2037: Technologies, Markets, Players, Forecasts

£€$元¥₩
Electronic (1-5 users)
£7,475.00
Electronic (6-10 users)
£10,465.00
Electronic and 1 Hardcopy (1-5 users)
£8,475.00
Electronic and 1 Hardcopy (6-10 users)
£11,465.00
Electronic (1-5 users)
€8,750.00
Electronic (6-10 users)
€12,250.00
Electronic and 1 Hardcopy (1-5 users)
€9,925.00
Electronic and 1 Hardcopy (6-10 users)
€13,420.00
Electronic (1-5 users)
$9,995.00
Electronic (6-10 users)
$13,990.00
Electronic and 1 Hardcopy (1-5 users)
$11,330.00
Electronic and 1 Hardcopy (6-10 users)
$15,325.00
Electronic (1-5 users)
元67,900.00
Electronic (6-10 users)
元95,000.00
Electronic and 1 Hardcopy (1-5 users)
元76,990.00
Electronic and 1 Hardcopy (6-10 users)
元104,050.00
Electronic (1-5 users)
¥1,200,000
Electronic (6-10 users)
¥1,692,000
Electronic and 1 Hardcopy (1-5 users)
¥1,416,000
Electronic and 1 Hardcopy (6-10 users)
¥1,908,000
Electronic (1-5 users)
₩15,130,000
Electronic (6-10 users)
₩21,180,000
Electronic and 1 Hardcopy (1-5 users)
₩17,150,000
Electronic and 1 Hardcopy (6-10 users)
₩23,200,000
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方はm.murakoshi@idtechex.com までご連絡ください。
Biomanufactured chemicals (excluding fuels) to grow at 13% CAGR from 2027-2037.

Report Statistics

Slides 311
Companies 40
Forecasts to 2037
Published Aug 2026
 

Preview Content

pdf Document Webinar slides - 100 Years of PHAs: Is Biomanufacturing Finally Ready for Take-Off?
pdf Document Sample pages
 

Customer Testimonial

quote graphic
"The resources provided by IDTechEx, such as their insightful reports and analysis, engaging webinars, and knowledgeable analysts, serve as valuable tools and information sources... Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
Global Head of Product Management and Marketing
Marquardt GmbH
 
 
 
ISBN: 9781835701904

Subscription Enquiry